Hematological dynamics following the co-administration of Resveratrol and Cisplatin in Sprague–Dawley rats.

<b>Background:</b>&nbsp;Cisplatin, a platinum-based chemotherapy&nbsp; agent, is used&nbsp; in&nbsp; the&nbsp; effective treatment&nbsp; of&nbsp; a&nbsp; wide&nbsp; range&nbsp; of&nbsp; malignant cancers. Resveratrol, a polyphenolic plant-deriv...

Full description

Bibliographic Details
Main Authors: Izuchukwu Azuka Okafor, Johnson Okwudili Nweke, Uchenna Somtochukwu Nnamah
Format: Article
Language:English
Published: National Scientific Medical Center 2018-06-01
Series:Ķazaķstannyṇ Klinikalyķ Medicinasy
Subjects:
Online Access:https://www.clinmedkaz.org/download/hematological-dynamics-following-the-co-administration-of-resveratrol-and-cisplatin-in-8963.pdf
_version_ 1818501727135989760
author Izuchukwu Azuka Okafor
Johnson Okwudili Nweke
Uchenna Somtochukwu Nnamah
author_facet Izuchukwu Azuka Okafor
Johnson Okwudili Nweke
Uchenna Somtochukwu Nnamah
author_sort Izuchukwu Azuka Okafor
collection DOAJ
description <b>Background:</b>&nbsp;Cisplatin, a platinum-based chemotherapy&nbsp; agent, is used&nbsp; in&nbsp; the&nbsp; effective treatment&nbsp; of&nbsp; a&nbsp; wide&nbsp; range&nbsp; of&nbsp; malignant cancers. Resveratrol, a polyphenolic plant-derived compound, has been shown to have several biological effects including protecting the body against several forms of damages.<br> <b>Objective:</b>&nbsp;This study assessed the effects of cisplatin and supplementation with resveratrol on some hematological parameters in Sprague-Dawley rats.<br> <b>Material and Methods:</b>&nbsp;Forty-five adult female Sprague–Dawley rats, grouped into 9, were used for this experimental study. Group 1 served as the control group and received distilled water only. Groups 2 and 9 received Cisplatin only while groups 3, 4, and 5 received different doses of Resveratrol after a single dose of Cisplatin. Groups 6, 7, and 8 received Resveratrol before Cisplatin.<br> <b>Results:</b>&nbsp;At the end of administration, blood samples were collected and different hematological parameters were accessed. Groups 2 and 5 showed a significantly higher Total WBC when compared to the control group (p&lt;0.05). Group 7 showed a significantly higher (p&lt;0.05) neutrophil count compared to both the control group and group 2, but a significant decrease in the lymphocyte count compared to the same groups (p&lt;0.05). Groups 6 and 7 showed a significant reduction in monocyte when compared to the control group (p&lt;0.05). There was no significant difference in the eosinophil count of all treatment groups when compared to the control group and cisplatin groups (p&lt;0.05). Basophil increased significantly in group 7 when compared to the control group and group 2 (p&lt;0.05). More so, a significant decrease in the Haemoglobin (Hb), Packed cell volume (PCV) and Mean corpuscular volume (MCV) level were observed when compared to group 9 (p&lt;0.05).<br> <b>Conclusion:</b>&nbsp;This study showed that cisplatin-induced alteration in some hematological parameters is reversible by treatment with resveratrol. More so, resveratrol supplementation should be incorporated as part of dietary nutrients for patients on cisplatin during chemotherapy.
first_indexed 2024-12-10T21:00:13Z
format Article
id doaj.art-c56b24875a0b4ccd9005fc8e3101efb6
institution Directory Open Access Journal
issn 1812-2892
2313-1519
language English
last_indexed 2024-12-10T21:00:13Z
publishDate 2018-06-01
publisher National Scientific Medical Center
record_format Article
series Ķazaķstannyṇ Klinikalyķ Medicinasy
spelling doaj.art-c56b24875a0b4ccd9005fc8e3101efb62022-12-22T01:33:50ZengNational Scientific Medical CenterĶazaķstannyṇ Klinikalyķ Medicinasy1812-28922313-15192018-06-01248222710.23950/1812-2892-JCMK-00563Hematological dynamics following the co-administration of Resveratrol and Cisplatin in Sprague–Dawley rats.Izuchukwu Azuka Okafor0Johnson Okwudili Nweke1Uchenna Somtochukwu Nnamah2Department of Anatomy, Faculty of Basic Medical Sciences, College of Health Sciences, Nnamdi Azikiwe University, Nnewi, Anambra State, NigeriaDepartment of Medical Laboratory Science, Iykenson Medical and Diagnostic Co. Ltd., Awka, Anambra State, NigeriaDepartment of Medical Laboratory Science, Nnamdi Azikiwe University Teaching Hospital, Nnewi, Anambra State, Nigeria<b>Background:</b>&nbsp;Cisplatin, a platinum-based chemotherapy&nbsp; agent, is used&nbsp; in&nbsp; the&nbsp; effective treatment&nbsp; of&nbsp; a&nbsp; wide&nbsp; range&nbsp; of&nbsp; malignant cancers. Resveratrol, a polyphenolic plant-derived compound, has been shown to have several biological effects including protecting the body against several forms of damages.<br> <b>Objective:</b>&nbsp;This study assessed the effects of cisplatin and supplementation with resveratrol on some hematological parameters in Sprague-Dawley rats.<br> <b>Material and Methods:</b>&nbsp;Forty-five adult female Sprague–Dawley rats, grouped into 9, were used for this experimental study. Group 1 served as the control group and received distilled water only. Groups 2 and 9 received Cisplatin only while groups 3, 4, and 5 received different doses of Resveratrol after a single dose of Cisplatin. Groups 6, 7, and 8 received Resveratrol before Cisplatin.<br> <b>Results:</b>&nbsp;At the end of administration, blood samples were collected and different hematological parameters were accessed. Groups 2 and 5 showed a significantly higher Total WBC when compared to the control group (p&lt;0.05). Group 7 showed a significantly higher (p&lt;0.05) neutrophil count compared to both the control group and group 2, but a significant decrease in the lymphocyte count compared to the same groups (p&lt;0.05). Groups 6 and 7 showed a significant reduction in monocyte when compared to the control group (p&lt;0.05). There was no significant difference in the eosinophil count of all treatment groups when compared to the control group and cisplatin groups (p&lt;0.05). Basophil increased significantly in group 7 when compared to the control group and group 2 (p&lt;0.05). More so, a significant decrease in the Haemoglobin (Hb), Packed cell volume (PCV) and Mean corpuscular volume (MCV) level were observed when compared to group 9 (p&lt;0.05).<br> <b>Conclusion:</b>&nbsp;This study showed that cisplatin-induced alteration in some hematological parameters is reversible by treatment with resveratrol. More so, resveratrol supplementation should be incorporated as part of dietary nutrients for patients on cisplatin during chemotherapy.https://www.clinmedkaz.org/download/hematological-dynamics-following-the-co-administration-of-resveratrol-and-cisplatin-in-8963.pdfcisplatinhematologyresveratrolSprague-Dawleysupplementation
spellingShingle Izuchukwu Azuka Okafor
Johnson Okwudili Nweke
Uchenna Somtochukwu Nnamah
Hematological dynamics following the co-administration of Resveratrol and Cisplatin in Sprague–Dawley rats.
Ķazaķstannyṇ Klinikalyķ Medicinasy
cisplatin
hematology
resveratrol
Sprague-Dawley
supplementation
title Hematological dynamics following the co-administration of Resveratrol and Cisplatin in Sprague–Dawley rats.
title_full Hematological dynamics following the co-administration of Resveratrol and Cisplatin in Sprague–Dawley rats.
title_fullStr Hematological dynamics following the co-administration of Resveratrol and Cisplatin in Sprague–Dawley rats.
title_full_unstemmed Hematological dynamics following the co-administration of Resveratrol and Cisplatin in Sprague–Dawley rats.
title_short Hematological dynamics following the co-administration of Resveratrol and Cisplatin in Sprague–Dawley rats.
title_sort hematological dynamics following the co administration of resveratrol and cisplatin in sprague dawley rats
topic cisplatin
hematology
resveratrol
Sprague-Dawley
supplementation
url https://www.clinmedkaz.org/download/hematological-dynamics-following-the-co-administration-of-resveratrol-and-cisplatin-in-8963.pdf
work_keys_str_mv AT izuchukwuazukaokafor hematologicaldynamicsfollowingthecoadministrationofresveratrolandcisplatininspraguedawleyrats
AT johnsonokwudilinweke hematologicaldynamicsfollowingthecoadministrationofresveratrolandcisplatininspraguedawleyrats
AT uchennasomtochukwunnamah hematologicaldynamicsfollowingthecoadministrationofresveratrolandcisplatininspraguedawleyrats